Clinical Trial Update: Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj [Phase 4]

View source ↗

Summary

This clinical trial update reports long-term immunogenicity and safety data after the fourth administration of Boryung's cell-culture Japanese encephalitis vacc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Boryung Cell-Culture Japanese Encephalitis Vaccine (Japanese encephalitis vaccine (cell culture))

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Japanese Encephalitis | Phase 4 | Status: COMPLETED